title: Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
authors.affiliation: From the Cardiology Division (C.M.H., P.R.K.) and Lankenau Institute for Medical Research (V.M.R., P.R.K.), Lankenau Medical Center, Wynnewood, PA. HanleyC@MLHS.org.
authors.forename: Colleen M
authors.initials: CM
authors.lastname: Hanley
authors.affiliation: From the Cardiology Division (C.M.H., P.R.K.) and Lankenau Institute for Medical Research (V.M.R., P.R.K.), Lankenau Medical Center, Wynnewood, PA.
authors.forename: Victoria M
authors.initials: VM
authors.lastname: Robinson
authors.affiliation: From the Cardiology Division (C.M.H., P.R.K.) and Lankenau Institute for Medical Research (V.M.R., P.R.K.), Lankenau Medical Center, Wynnewood, PA.
authors.forename: Peter R
authors.initials: PR
authors.lastname: Kowey
mesh_terms: D000200:Action Potentials; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D006329:Heart Conduction System / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D058990:Molecular Targeted Therapy; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D015507:Drugs, Investigational
keywords: amiodarone; atrial fibrillation; catheter ablation; flecainide; vernakalant